Alerts will be sent to your verified email
Verify Email
AAREYDRUGS
|
Aarey Drugs & Pharma
|
Aptus Pharma
|
Brooks Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.4 % | 36.58 % | -21.13 % |
|
5yr average Equity Multiplier
|
2.28 | 5.05 | 1.68 |
|
5yr Average Asset Turnover Ratio
|
1.58 | 1.72 | 0.62 |
|
5yr Avg Net Profit Margin
|
1.23 % | 6.16 % | -21.45 % |
|
Price to Book
|
1.2 | 26.27 | 1.53 |
|
P/E
|
49.98 | 59.16 | 15.37 |
|
5yr Avg Cash Conversion Cycle
|
60.21 Days | 88.73 Days | 23.75 Days |
|
Inventory Days
|
21.8 Days | 64.83 Days | 83.11 Days |
|
Days Receivable
|
122.43 Days | 65.8 Days | 80.26 Days |
|
Days Payable
|
103.05 Days | 77.01 Days | 163.46 Days |
|
5yr Average Interest Coverage Ratio
|
3.59 | 6.23 | -11.18 |
|
5yr Avg ROCE
|
8.53 % | 28.46 % | -11.18 % |
|
5yr Avg Operating Profit Margin
|
1.54 % | 10.95 % | -10.26 % |
|
5 yr average Debt to Equity
|
0.22 | 2.26 | 0.18 |
|
5yr CAGR Net Profit
|
-9.19 % | 74.79 % | -12.45 % |
|
5yr Average Return on Assets
|
1.94 % | 8.44 % | -13.31 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
39.06 % | 72.89 % | 52.62 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-10.97 % | 0.0 | -13.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 9.9 % |
|
Aarey Drugs & Pharma
|
Aptus Pharma
|
Brooks Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|